ArticleClinical parkinsonism & related disorders2025
Motor asymmetry in Parkinson's disease: Diagnostic thresholds based on clinical scores and DaTSCAN imaging.
Article in Clinical parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Is motor asymmetry a predictor of non-motor outcomes in Parkinson's disease?Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- Striatal (a-)symmetry reveals sex-specific autonomic vulnerabilities in early Parkinson's disease.npj women's health · 2026Article
- Mapping motor cortex "hand knob" metrics to symptom hemidominance in Parkinson's disease: from width comparison to machine learning.Brain & spine · 2026Article
- Gene expression asymmetry in Parkinson's disease: variation ofFrontiers in molecular neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motor asymmetry is a key feature of Parkinson's disease that can influence disease progression and patient outcomes. However, there is currently no consensus on the best method or clear thresholds to determine motor asymmetry, which limits the ability to standardize its assessment across studies. This work aimed to determine which motor asymmetry score - standardized or non-standardized - best predicts dopaminergic damage in the putamen, as measured by DaTSCAN, and to establish clear thresholds for distinguishing symmetric from asymmetric profiles. Data from the Parkinson's Progression Markers Initiative were utilized for the Receiver Operating Characteristic curve analysis. Both motor asymmetry scores significantly predicted dopaminergic asymmetry, with the non-standardized score showing a slightly higher predictive power (area under the curve [AUC] = 0.621, p < 0.001) compared to the standardized score (AUC = 0.569, p = 0.018). For the non-standardized score, a cut-off of ± 2.50 yielded a sensitivity of 0.874 and specificity of 0.783. In contrast, the standardized score achieved a cut-off of ± 0.188, resulting in a sensitivity of 0.908 and specificity of 0.823. These findings underscore the importance of motor asymmetry in clinical evaluations of Parkinson's disease and provide a foundation for further research aimed at refining diagnostic thresholds.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.